The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
HIV-1 risk and vaccine acceptability in the Ugandan military.
D L Hom; J L Johnson; P Mugyenyi; R Byaruhanga; C Kityo; A Louglin; G M Svilar; M Vjecha; R D Mugerwa; J J Ellner (Profiled Author: Jerrold Ellner)
Department of Medicine, Case Western Reserve University and University Hospitals of Cleveland, Ohio 44106-4984, U.S.A. firstname.lastname@example.org
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(5):375-80.
Between July and October 1993, 570 19- to 22-year-old volunteers were screened for HIV-1, with a resulting seroprevalence rate of 18.3% (95% CI: 14.0%, 22.6%). A cohort of 249 HIV-1-noninfected military recruits in the Ugandan Peoples' Defense Forces was followed prospectively for up to 18 months to document rates of HIV-1 seroprevalence, seroconversion, and knowledge and attitudes related to vaccine acceptability. The HIV-1 seroincidence rate was 3.56 per 100 person-years (95% CI: 1.49, 5.62) over 309 person-years of observation. At the 3- and 12-month visits, subjects were interviewed on issues of acceptance and knowledge about vaccines, including anti-HIV vaccines in particular. More than 90% believe that HIV vaccines will not cause HIV infection, and if offered, 88% report that they would take the vaccine if they were not already infected. Nonvaccine prevention methods were considered less reliable; monogamy and condom use were considered effective by only 33.5% and 69.3% of the cohort respectively. After completing the vaccine acceptability questionnaire at the 12-month visit, subjects were offered an approved polyvalent meningococcal vaccine as an indicator of general vaccine acceptance. All subjects reported receiving at least one previous vaccination, and 95% willingly accepted the meningococcal vaccination. The Ugandan military is a stable population at substantial risk for HIV-1 infection and may be a suitable population for vaccine efficacy trials.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
David Bishai; George Pariyo; Martha Ainsworth; Kenneth HillBulletin of the World Health Organization 2004;82(9):652-60.
H Cao; P Kaleebu; D Hom; J Flores; D Agrawal; N Jones; J Serwanga; M Okello; C Walker; H Sheppard; et al.The Journal of infectious diseases 2003;187(6):887-95.
J Smith; F Nalagoda; M J Wawer; D Serwadda; N Sewankambo; J Konde-Lule; T Lutalo; C Li; R H GrayInternational journal of STD & AIDS 1999;10(7):452-9.
Appears in this Publication
Author of this Publication